Company / Operating Income per Share
ADMA Biologics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.81
FY2025
5-year range
-$0.56 / $0.81
FY2021-FY2025
Trend
+31.6%
vs FY2024
Sector context
#39 of 201
Health Care
What the data says
ADMA Biologics, Inc.'s operating income per share of $0.81 is higher than 81% of companies in the Health Care sector (FY2025). Operating Income per Share has increased for 5 consecutive years, from $-1.09 in FY2020 to $0.81 in FY2025.
Based on SEC 10-K filings.
0.81 in FY2025. Top quartile in the Health Care sector.
Improved from $0.10 to $0.81 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+125.0% above sector average
Key checks
Key Insights
- ADMA Biologics, Inc.'s operating income per share has grown for 5 consecutive years.
- In FY2025, operating income per share increased 31.6% year-over-year.
- Ranks #39 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.81 | +31.6% |
| FY2024 | $0.61 | +530.4% |
| FY2023 | $0.10 | +132.7% |
| FY2022 | -$0.30 | +46.4% |
| FY2021 | -$0.56 | +49.2% |
| FY2020 | -$1.09 | -22.5% |
| FY2019 | -$0.89 | +45.6% |
| FY2018 | -$1.64 | -22.1% |
| FY2017 | -$1.34 | +16.9% |
| FY2016 | -$1.62 | +6.2% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026